| Status: AWMSG assessment in progress | |
As maintenance therapy for eosinophilic esophagitis in adults (older than 18 years of age). |
|
Medicine details |
|
| Medicine name | budesonide (Jorveza®) |
| Formulation | 0.5 mg and 1 mg orodispersible tablet |
| Reference number | 4507 |
| Indication | As above |
| Company | Dr Falk Pharma UK Ltd |
| BNF chapter | Gastro-intestinal system |
| Assessment type | Limited |
| Status | AWMSG assessment in progress |
| Scrutiny Panel meeting date | 03/11/2025 |
| LOWMAG meeting date | 15/04/2026 |
| AWMSG meeting date | 20/05/2025 |
| Date of issue | 24/09/2020 |